logo

For the Inventor, By the Inventor

Lexington, MA, United States of America

Xue-Jun Kong

This inventor holds 3 USPTO granted patents and 5 published patent applications. Top assignee: The General Hospital Corporation. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xue-Jun Kong. Retrieved from https://idiyas.com/inventor/xue-jun-kong

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 33.3

Average Co-Inventor Count = 1.5

ph-index = 1


Company Filing History:

goldMedal3 out of 3,076 
 
The General Hospital Corporation
 patents

Years Active: 2026

Loading Chart...
3 patents (USPTO):Explore Patents
1. 12746264 - PROBIOTICS COMPOSITIONS AND METHOD OF USING THE SAME TO ENHANCE GROWTH AND SOCIAL FUNCTION IN CHILDREN (2026-09-29),
2. 12746262 - PROBIOTICS COMPOSITIONS AND METHOD OF USING THE SAME TO ENHANCE GROWTH AND SOCIAL FUNCTION IN CHILDREN (2026-09-29),
3. 12678092 - Systems and methods for assessing medical conditions such as inflammation, autoimmunity, and Autism Spectrum Disorder (ASD), and treatments thereof (2026-07-14),

Title: Innovations by Xue-Jun Kong in Medical Assessment Technologies

Introduction

Xue-Jun Kong is an accomplished inventor based in Lexington, MA (US). He has made significant contributions to the field of medical technology, particularly in assessing various medical conditions. His innovative work focuses on developing systems that can evaluate and treat conditions such as inflammation, autoimmunity, and Autism Spectrum Disorder (ASD).

Latest Patents

Xue-Jun Kong holds a patent for a groundbreaking system designed to assess medical conditions. The patent, titled "Systems and methods for assessing medical conditions such as inflammation, autoimmunity, and Autism Spectrum Disorder (ASD), and treatments thereof," outlines a system that includes a processor in communication with a carbon monoxide (CO) detector. The system is capable of receiving a measure of CO from a subject suspected of having ASD, autoimmunity, or inflammation. It also obtains levels of biomarkers associated with the subject and generates a report based on this data. This innovative approach has the potential to enhance the evaluation and treatment of these medical conditions.

Career Highlights

Xue-Jun Kong is affiliated with The General Hospital Corporation, where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on medical diagnostics and treatment methodologies. With a focus on integrating technology with healthcare, Kong's contributions are paving the way for more effective medical assessments.

Collaborations

Xue-Jun Kong collaborates with esteemed colleagues, including Kenneth Kwong and Suk-Tak Chan. Their combined expertise fosters an environment of innovation and progress in the medical technology sector.

Conclusion

Xue-Jun Kong's innovative work in medical assessment technologies exemplifies the intersection of technology and healthcare. His patent for assessing conditions like ASD and autoimmunity showcases the potential for improved diagnostic methods. Through his contributions, Kong is making a significant impact on the future of medical evaluations and treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…